Digirad (NSDQ:DRAD) met an analyst’s earnings expectations and beat the sales forecast, sending share prices up slightly today.
Suwanee, Ga.-based Digirad posted net losses of -$350,000 or -2¢ per share on sales of $27.1 million for the three months ended June 30, cutting its losses by -80.2% on sales growth of 4.1% compared with Q2 2017.
A Wall Street analyst predicted losses of -2¢ on sales of $26.3 million.
“Overall, our business performed well during the quarter,” Digirad president & CEO Matt Molchan said in prepared remarks. “Diagnostic services led the way with a great quarter showing gains year over year in revenue and gross profit. Our continued, focused efforts in our interim rental business within mobile healthcare have yielded significant gains as well, with quarterly interim sales increasing 14% year over year.”
The company sold its medical device sales and service business and associated contracts to Royal Philips (NYSE:PHG) for $8 million in February.
DRAD shares were up 1.4% to $1.80 apiece today in midday trading.